Literature DB >> 34197606

PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair.

Bin Peng1, Ruifeng Shi1,2, Jing Bian1, Yuwei Li1, Peipei Wang1, Hailong Wang3, Ji Liao1, Wei-Guo Zhu1, Xingzhi Xu1,2.   

Abstract

Polo-like kinase 1 (PLK1) is a master kinase that regulates cell cycle progression. How its enzymatic activity is regulated in response to DNA damage is not fully understood. We show that PLK1 is enriched at double strand breaks (DSBs) within seconds of UV laser irradiation in a PARP-1-dependent manner and then disperses within 10 min in a PARG-dependent manner. Poly(ADP-)ribose (PAR) chains directly bind to PLK1 in vitro and inhibit its enzymatic activity. CHK1-mediated PLK1 phosphorylation at S137 prevents its binding to PAR and recruitment to DSBs but ensures PLK1 phosphorylation at T210 and its enzymatic activity toward RAD51 at S14. This subsequent phosphorylation event at S14 primes RAD51 for CHK1-mediated phosphorylation at T309, which is essential for full RAD51 activation. This CHK1-PLK1-RAD51 axis ultimately promotes homologous recombination (HR)-mediated repair and ensures chromosome stability and cellular radiosensitivity. These findings provide biological insight for combined cancer therapy using inhibitors of PARG and CHK1.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 34197606     DOI: 10.1093/nar/gkab584

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  7 in total

Review 1.  Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer.

Authors:  Nitasha Gupta; Tzu-Ting Huang; Sachi Horibata; Jung-Min Lee
Journal:  Pharmacol Res       Date:  2022-03-05       Impact factor: 10.334

Review 2.  Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response.

Authors:  Karla E Lopez; Lisa Bouchier-Hayes
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

3.  Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma.

Authors:  Er-Can Sun; Shuang-Shuang Dong; Zhi-Jun Li; Chang-Xue Li
Journal:  Dis Markers       Date:  2022-06-17       Impact factor: 3.464

Review 4.  Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.

Authors:  Michela Chiappa; Serena Petrella; Giovanna Damia; Massimo Broggini; Federica Guffanti; Francesca Ricci
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

5.  Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.

Authors:  Zhaoshui Li; Zaiqi Ma; Hong Xue; Ruxin Shen; Kun Qin; Yu Zhang; Xin Zheng; Guodong Zhang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

6.  Intrinsic ROS Drive Hair Follicle Cycle Progression by Modulating DNA Damage and Repair and Subsequently Hair Follicle Apoptosis and Macrophage Polarization.

Authors:  Mingsheng Liu; Xiaomei Liu; Yuan Wang; Yutong Sui; Feilin Liu; Zinan Liu; Fei Zou; Kuiyang Zuo; Ziyu Wang; Wei Sun; Qi Xu; Dan Liu; Jinyu Liu
Journal:  Oxid Med Cell Longev       Date:  2022-07-14       Impact factor: 7.310

7.  PLK1-mediated phosphorylation of PPIL2 regulates HR via CtIP.

Authors:  Zhiyu Qiu; Shuailin Hao; Shikai Song; Ruiling Zhang; Tingyu Yan; Zhifang Lu; Hailong Wang; Zongchao Jia; Jimin Zheng
Journal:  Front Cell Dev Biol       Date:  2022-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.